TheProfitWatch

AQST - Aquestive Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.69 0.02 (0.44%) 0.0 (0.0%) -0.01 (-0.17%) 0.04 (0.7%) -0.15 (-2.64%) 0.17 (3.16%) -0.06 (-1.01%) -0.11 (-1.95%)

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.14
Diluted EPS:
-0.14
Basic P/E:
-40.8214
Diluted P/E:
-40.8214
RSI(14) 1m:
55.56
VWAP:
5.72
RVol:

Events

Period Kind Movement Occurred At

Related News